Chemiesynth (Vapi) Ltd
Chemiesynth (Vapi) Ltd (CHEMIESYNT) last reported results for the quarter ended Jun 2026, with sales of ₹4.2 crore and net profit of ₹-0.58 crore. The stock last traded at ₹104, a market capitalisation of ₹31.8 crore. Over the past 52 weeks the stock has ranged between ₹37.6 and ₹104. Figures are as of 6 Oct 2026 and are not real time.
Chemiesynth (Vapi) Ltd share price and key metrics
- Current price
- ₹104
- Market cap
- ₹31.8 cr
- Book value
- ₹32.7
- ROE
- -9.42%
- ROCE
- -0.15%
- Dividend yield
- 0.00%
- 52w high / low
- 104/37.6
Metrics as of 6 Oct 2026. Not real time.
Track Chemiesynth (Vapi) Ltd
Cruxal reads every Chemiesynth (Vapi) Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Chemiesynth (Vapi) Ltd growth and returns
- 10 Years
- 15%
- 5 Years
- 2%
- 3 Years
- 1%
- TTM
- 8%
- 10 Years
- -15%
- 5 Years
- %
- 3 Years
- %
- TTM
- -250%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 70%
- 1 Year
- %
- 10 Years
- 10%
- 5 Years
- 2%
- 3 Years
- -4%
- Last Year
- -9%
Chemiesynth (Vapi) Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹4.2 cr, up 5.8% from ₹3.97 cr a year earlier. Net profit was ₹-0.58 cr, down 26.1% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 5.47 | 3.88 | 6.68 | 3.97 | 6.87 | 5.09 | 5.5 | 4.2 |
| Expenses | 4.51 | 3.65 | 5.87 | 3.79 | 6.68 | 5.15 | 4.45 | 4.16 |
| Operating profit | 0.96 | 0.23 | 0.81 | 0.18 | 0.19 | -0.06 | 1.05 | 0.04 |
| OPM % | 17.55% | 5.93% | 12.13% | 4.53% | 2.77% | -1.18% | 19.09% | 0.95% |
| Other income | 0 | 0 | 0.01 | 0 | 0 | 0 | 0.01 | 0.02 |
| Interest | 0.17 | 0.34 | 0.2 | 0.25 | 0.27 | 0.26 | 0.22 | 0.28 |
| Depreciation | 0.38 | 0.36 | 0.33 | 0.39 | 0.36 | 0.38 | 0.3 | 0.36 |
| Profit before tax | 0.41 | -0.47 | 0.29 | -0.46 | -0.44 | -0.7 | 0.54 | -0.58 |
| Tax % | 0.00% | 0.00% | 34.48% | 0.00% | 0.00% | 0.00% | -11.11% | 0.00% |
| Net profit | 0.42 | -0.47 | 0.19 | -0.46 | -0.44 | -0.7 | 0.6 | -0.58 |
| EPS (₹) | 1.37 | -1.53 | 0.62 | -1.50 | -1.43 | -2.28 | 1.95 | -1.89 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Chemiesynth (Vapi) Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.09 | 13.32 | 11.2 | 14.56 | 19.9 | 30.18 | 20.94 | 16.43 | 18.89 | 21.44 | 21.66 |
| Operating profit | -0.08 | 0.65 | 1.94 | 2.29 | 5.58 | 4.47 | 2.57 | 1.55 | 2.21 | 1.37 | 1.22 |
| OPM % | -2.59% | 4.88% | 17.32% | 15.73% | 28.04% | 14.81% | 12.27% | 9.43% | 11.70% | 6.39% | 5.63% |
| Net profit | -0.18 | 0.39 | 1.17 | 1.31 | 3.56 | 2.72 | 0.56 | -0.39 | -0.11 | -0.99 | -1.12 |
| EPS (₹) | -0.59 | 1.27 | 3.81 | 4.27 | 11.60 | 8.86 | 1.82 | -1.27 | -0.36 | -3.22 | -3.65 |
TTM is the trailing twelve months to the most recent quarter.
Chemiesynth (Vapi) Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 |
| Reserves | -1.05 | -0.66 | 0.52 | 1.83 | 5.39 | 8.10 | 8.66 | 8.27 | 7.91 | 6.98 |
| Borrowings | 8.02 | 8.01 | 7.69 | 9.73 | 10.86 | 11.60 | 13.63 | 15.54 | 15.02 | 16.03 |
| Other liabilities | 1.58 | 1.48 | 3.59 | 3.18 | 7.55 | 6.86 | 5.65 | 4.49 | 6.19 | 5.95 |
| Total liabilities | 11.62 | 11.90 | 14.87 | 17.81 | 26.87 | 29.63 | 31.01 | 31.37 | 32.19 | 32.03 |
| Fixed assets | 9.71 | 9.62 | 10.69 | 12.31 | 20.39 | 22.38 | 24.51 | 25.08 | 25.83 | 27.29 |
| CWIP | 0.00 | 0.00 | 0.24 | 1.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other assets | 1.91 | 2.28 | 3.94 | 4.16 | 6.48 | 7.25 | 6.50 | 6.29 | 6.36 | 4.74 |
| Total assets | 11.62 | 11.90 | 14.87 | 17.81 | 26.87 | 29.63 | 31.01 | 31.37 | 32.19 | 32.03 |
As reported by the company. Total assets equal total liabilities by construction.
Chemiesynth (Vapi) Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -0.13 | 0.56 | 2.56 | 1.28 | 6.49 | 2.90 | 0.27 | -0.03 | 2.65 | 1.89 |
| Cash from investing | 0.32 | -0.38 | -1.71 | -3.20 | -7.51 | -3.05 | -3.29 | -1.87 | -2.14 | -2.91 |
| Cash from financing | -0.16 | -0.16 | -0.45 | 1.70 | 1.13 | 0.74 | 2.04 | 1.90 | -0.52 | 1.01 |
| Net cash flow | 0.03 | 0.01 | 0.40 | -0.22 | 0.11 | 0.59 | -0.98 | 0.01 | -0.01 | -0.01 |
| Free cash flow | 0.18 | 0.17 | 0.83 | -1.93 | -1.02 | -0.15 | -3.02 | -1.90 | 0.50 | -1.03 |
| CFO / operating profit | 162% | 86% | 145% | 66% | 122% | 89% | 32% | 8% | 121% | 136% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Chemiesynth (Vapi) Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | -2.44% | 5.28% | 13.73% | 13.89% | 28.39% | 16.35% | 5.82% | 1.00% | 3.10% | -0.15% |
| Debtor days | 24.81 | 27.13 | 55.08 | 39.86 | 67.86 | 41.60 | 47.24 | 47.10 | 55.07 | 30.13 |
| Inventory days | 580.41 | 16.18 | 231.23 | 217.06 | 165.17 | 80.99 | 200.09 | 386.19 | 167.61 | 129.87 |
| Days payable | 741.97 | 43.60 | 605.79 | 366.21 | 695.35 | 159.36 | 200.78 | 111.85 | 201.64 | 193.44 |
| Cash conversion cycle | -136.75 | -0.29 | -319.48 | -109.29 | -462.31 | -36.77 | 46.55 | 321.44 | 21.04 | -33.43 |
| Working capital days | -103.95 | -9.04 | -28.68 | -60.92 | -65.85 | -49.83 | -65.89 | -105.08 | -122.12 | -149.13 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Chemiesynth (Vapi) Ltd shareholding pattern
Promoters held 62.35% at Jun 2026, broadly unchanged since Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 62.35% | 62.35% | 62.35% | 62.35% | 62.35% | 62.35% | 62.35% | 62.35% |
| Public | 37.66% | 37.66% | 37.66% | 37.66% | 37.66% | 37.66% | 37.66% | 37.66% |
| No. of shareholders | 525 | 525 | 524 | 524 | 524 | 523 | 526 | 528 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Chemiesynth (Vapi) Ltd corporate filings
- compliance under Regulation 74(5) od SEBI (DP) Regulation, 2018Company Updatelow impact
- Company Approves Multiple Resolutions at 40th AGM, Including Capital Increase, Related Party Transactions, and Articles of Association AmendmentsAGM/EGMhigh impact
Cruxal's analysis: Chemiesynth (Vapi) Limited held its 40th AGM on 30th September 2026, with all resolutions…
Read the full analysis - Chemiesynth (Vapi) Limited holds 40th AGM; no immediate financial disclosures or strategic events announcedAGM/EGMlow impact
Cruxal's analysis: Chemiesynth (Vapi) Limited conducted its 40th Annual General Meeting on September 30…
Read the full analysis - Chemiesynth (Vapi) Limited holds its 40th AGM, considering financial statements, reappointment of director, and multiple strategic resolutions including share capital increase and issuance of unlisted preference shares.AGM/EGMhigh impact
Cruxal's analysis: Chemiesynth (Vapi) Limited conducted its 40th AGM on September 30, 2026, with key agenda…
Read the full analysis - Intimation of Closure of trading window for the half year ended 30 September, 2026.Insider Trading / SASTlow impact
- Chemiesynth (Vapi) Ltd announces newspaper publication for 40th Annual General MeetingCompany Updatelow impact
Cruxal's analysis: Chemiesynth (Vapi) Ltd has fulfilled regulatory requirements under Regulation 30 of the…
Read the full analysis - Chemiesynth (Vapi) Ltd issues routine shareholder communication via weblinkCompany Updatelow impact
Cruxal's analysis: Chemiesynth (Vapi) Ltd has filed a disclosure regarding a letter sent to shareholders via…
Read the full analysis - Chemiesynth (Vapi) Ltd files Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Chemiesynth (Vapi) Ltd has submitted its Annual Report for the financial year 2025-26 as…
Read the full analysis - Chemiesynth (Vapi) Limited to seek shareholder approval for INR 15 crore preference share issuance and related party transactions at 40th AGMAGM/EGMmedium impact
Cruxal's analysis: Chemiesynth (Vapi) Limited has announced its 40th Annual General Meeting scheduled for…
Read the full analysis - Chemiesynth (Vapi) Limited Reports Net Loss of 58.37 Lakh for Quarter Ended June 2026Company Updatelow impact
Cruxal's analysis: Chemiesynth (Vapi) Limited has disclosed its unaudited financial results for the quarter…
Read the full analysis - Chemiesynth (Vapi) Limited issues corrigendum to rectify clerical errors in AGM and Benpose datesCompany Updatelow impact
Cruxal's analysis: Chemiesynth (Vapi) Limited has issued a formal corrigendum to correct clerical errors…
Read the full analysis - Chemiesynth (Vapi) Limited reports Q1 FY27 net loss of 0.58 crore; announces capital restructuring and preference share issuanceBoard Meetingmedium impact
Cruxal's analysis: Chemiesynth (Vapi) Limited reported a net loss of 0.58 crore for the quarter ended June…
Read the full analysis - Chemiesynth (Vapi) Limited schedules board meeting to consider Q1 FY27 results and capital restructuring via preference sharesBoard Meetingmedium impact
Cruxal's analysis: Chemiesynth (Vapi) Limited has announced a board meeting scheduled for August 12, 2026…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.